Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.700 | None | 0.979 | 1 | 0 | 1996 | 2020 | ||||||||
|
solute carrier family 5 member 7 | 0.597 | 0.654 | 1.5E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
toll like receptor 3 | 0.427 | 0.885 | 1.6E-07 |
|
disease | 0.260 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.290 | None | 0.800 | 1 | 0 | 2005 | 2017 | ||||||||
|
solute carrier family 22 member 1 | 0.556 | 0.731 | 1.5E-22 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
solute carrier family 18 member A3 | 0.608 | 0.654 | 0.45 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
complement C3a receptor 1 | 0.601 | 0.731 | 3.3E-09 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
surfactant protein D | 0.500 | 0.846 | 7.5E-05 |
|
disease | 0.290 | None | 0.900 | 1 | 0 | 2006 | 2020 | ||||||||
|
surfactant protein B | 0.575 | 0.654 | 2.6E-04 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
C-C motif chemokine ligand 22 | 0.500 | 0.846 | 8.4E-03 |
|
disease | 0.270 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
C-C motif chemokine ligand 17 | 0.518 | 0.808 | 1.4E-04 |
|
disease | 0.300 | None | 0.917 | 1 | 0 | 2001 | 2019 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2000 | 2004 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
disease | 0.270 | None | 0.875 | 1 | 0 | 2000 | 2017 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.600 | None | 0.886 | 1 | 0 | 1996 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 0.875 | 1 | 0 | 2001 | 2019 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.250 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2005 | 2013 | ||||||||
|
mucin 5AC, oligomeric mucus/gel-forming | 0.483 | 0.808 | 1.0E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2020 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.240 | None | 1.000 | 1 | 0 | 2008 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 1999 | 2007 | ||||||||
|
angiotensin II receptor type 2 | 0.496 | 0.808 | 8.2E-03 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.210 | None | 0.500 | 1 | 0 | 2001 | 2008 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.290 | None | 1.000 | 1 | 0 | 2012 | 2019 |